rss
Thorax 1982;37:617-619 doi:10.1136/thx.37.8.617
  • Research Article

Effects of naftidrofuryl on breathlessness and exercise tolerance in chronic bronchitis.

  1. A J Williams,
  2. J Osman,
  3. C Skinner

      Abstract

      Naftidrofuryl enhances oxidative phosphorylation and might therefore be expected to improve exercise tolerance and breathlessness in advanced chronic bronchitis. This hypothesis was tested in a four-week placebo-controlled trial in 11 bronchitic patients. Seven patients completed the study. There was no evidence of any benefit from naftidrofuryl either subjectively or after a 12-minute walking test.

      This Article

      1. Abstract
      2. PDF

      Social bookmarking

      Register for free content


      Free sample
       This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
      View free sample issue >>

      Free archive
      The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
      Register to access the free archive >>

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.